Gillian Sandler has two decades of experience as a Chairman & CEO, board member, corporate strategist, advisor, activist investor, entrepreneur, and Equity Research analyst.  

She has also provided support to and collaborated with countless think tanks, scientists, inventors, investment funds, non-­profits, entrepreneurs, and family investments & causes in the U.S. and internationally.

She currently serves as a member of:

Gillian is a lead investor and Board Member in AZTherapies, which has the most advanced Phase 3 clinical trial to treat early stage Alzheimer’s through a multi-action approach targeting inflammation and microglia. She previously was a lead investor and served on the Board of Directors of Invicro [sold to Konica Minolta 4Q/17) after having co-led the financing for the acquisition of Molecular Neuro Imaging (MNI).  Invicro is the leader in providing the most advanced imaging solutions to life sciences companies from discovery research through Phase 3 clinical trials. Their innovative imaging work in the field of Alzheimer’s and cancer immunotherapy is critical to reducing the cost and time to get effective new treatments to market safely.

Other direct investments in the healthcare and life sciences space include MymeeEnvisagenicsBioAtla, CaptureProof, and Cortexyme.

She was previously the CEO & Chairman of Todobebe, Inc from 2001 to 2012 (sold to Entravision (EVC) 2012). In this role, she received the 1st Pioneer Award for Changing Health Disparity among underserved populations by former U.S. Surgeon General Richard Carmona, and was nominated as a top CEO of Hispanic Media companies by Hispanic Ad (2010 & ‘11).

Under her leadership, Todobebe grew from the first global website for Spanish & Portuguese speaking parents expecting and raising children 0-5 years old, to a recognized pioneer in the Hispanic market globally across Broadcast TV (over 250 episodes), Digital, Radio, Events, Marketing, Research, Mobile, Publishing, and Licensing, anchored by award winning Television and digital properties, and multi-year partnerships with the top distribution platforms in the market (Univision, Telemundo-NBC, Televisa, Walmart).

She also served on the Advisory Board of the Pediatric Brain Injury (PBI) Program, U of Miami School of Medicine (the pediatric arm of The Miami Project) a leading center for the prevention, research, and rehabilitation of children with severe brain injury.

She also served for 8 years on the Board of Directors of Medcenter Solutions, the leading CRM Pharmaceutical marketing and Continuing Medical Education Company serving Latin America.

She was previously the co-Founder & first CEO of Wallaware, Inc, a next generation mobile software company with a platform and API and simple SDK to enable telco’s to securely control, manage, analyze, develop use cases, drive apps development, and monetize consumer and enterprise mobile data use.

During her tenure it was ranked as a top-4 emerging mobile technology company in Europe by Tornado Insider (‘00), and was selected by IBM as its first “Blue Light” case study supporting emerging mobile tech companies (‘01).

Prior to that, Gillian was a Director of Spydre Labs, LLC a seed stage investment company majority owned by WPP for investing in and operating start-up companies in Latin America.

She was also a Strategist with AppNet/CMRC where her role was to advise Fortune 500 corporations across consumer products, healthcare, finance, media and publishing on how to leverage their assets to prepare for long term growth in a rapidly changing technology, telecom & media landscape – build/buy/partner, 10 year business plan development, deal structures, valuation, negotiation.

She was also an equity analyst at JPMorgan, on the team that earned the #1 Institutional Investor ranking for the Telecom Industry in Latin America. She covered privatizations and IPOs across the region, and wrote extensively on the future of the emerging wireless industry.

She also worked in JP Morgan Global Credit developing credit ratings and recommendations behind loans to the largest U.S. retailers during a period of rapid industry transition and high number of bankruptcies (1995).

In October 2012 and February 2013 she completed the Executive Programs “FutureMed” and “Singularity” at Singularity University at NASA/Ames in Mountain View California.

At JPMorgan, she completed the Management Services training program, the Equity Research training program, and received her Series 7 and Series 63 certifications.

Gillian received a BA and Certificate for International Relations with a focus on Developing Economies from Wesleyan University (CT), and ran for the University Track & Cross Country teams.

Prior to University, she worked for a semester at JPL/NASA doing programming (IDL) and satellite industry research.